Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) FCF Margin (2017 - 2025)

Autolus Therapeutics (AUTL) has disclosed FCF Margin for 4 consecutive years, with 253.97% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 253.97%, compared with a TTM value of 497.92% through Sep 2025, up 145789.0%, and an annual FY2024 reading of 2055.97%, up 716506.0% over the prior year.
  • FCF Margin was 253.97% for Q3 2025 at Autolus Therapeutics, up from 382.63% in the prior quarter.
  • Across five years, FCF Margin topped out at 253.97% in Q3 2025 and bottomed at 184190.0% in Q4 2024.
  • Average FCF Margin over 3 years is 28773.3%, with a median of 933.07% recorded in 2025.
  • The sharpest move saw FCF Margin soared 315714bps in 2024, then tumbled -52666bps in 2025.
  • Year by year, FCF Margin stood at 11683.5% in 2023, then plummeted by -1476bps to 184190.0% in 2024, then surged by 100bps to 253.97% in 2025.
  • Business Quant data shows FCF Margin for AUTL at 253.97% in Q3 2025, 382.63% in Q2 2025, and 933.07% in Q1 2025.